Point Of Care Diagnostics Market to Approach USD 40.50 Billion by 2022

Published By: Zion Market Research
Global Point Of Care Diagnostics Market Set for Rapid
Growth to Reach around USD 40.50 Billion by 2022
Contact Us:
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
sales@zionmarketresearch.com

Point Of Care Diagnostics Market
Zion Market Research has published a new report titled “Point Of Care Diagnostics Market
by Products, by Prescription Mode (Prescription-Based Testing Kits and Over-The-
Counter Testing Kits) Market for Hospitals, Clinics and Ambulatory Care Settings:
Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 –
2022”. According to the report, the global point of care diagnostics market was valued at
approximately USD 23.50 billion in 2016 and is expected to reach approximately USD 40.50
billion by 2022, growing at a CAGR of around 10.00% between 2017 and 2022.
The point of Care Diagnostics is medical testing performed at the clinical laboratory in close
proximity to where the patient is receiving care. POCT is usually performed by non-laboratory
persons and the results are used for clinical decision making. Point- of-care technologies may
enhance the management of different diseases and conditions. The point of Care diagnostics is
of great importance in developing countries. Unfortunately, a major aspect in developing
countries is that they often lack modern laboratories, fully automated instruments that provide
highly reproducible, quantitative, and hence sensitive and accurate diagnostic results. In order
to circumvent these issues, the emergence of rapid and easy-to-use point-of-care (POC) tests
can dramatically enhance a physician’s ability to diagnose patients’ diseases rapidly and
accurately.

Point Of Care Diagnostics Market
The point of care diagnostics market is expected to witness lucrative growth in the near future.
The market is mainly driven by technological advancement and cost-effective and high-quality
medical solutions. Moreover, increasing prevalence of target diseases coupled with the rise in
the aging population base which is more prone to disease growth are attributive to impact the
POCT demand considerably over the years to come. However, the high cost of procedure and
presence of stringent and time-consuming ambiguous regulatory framework are expected to
hamper the market growth within the forecast period. Nonetheless, increasing demand from
emerging economies and health care decentralization may open up new growth avenues in the
near future.
Request Free Sample copy of Global Point Of Care Diagnostics Market Report @
https://www.zionmarketresearch.com/sample/point-of-care-diagnostics-market
The market can be segmented on the basis of products into glucose monitoring kits, cardiometabolic
monitoring kits, infectious diseases testing kits, coagulation monitoring kits,
pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, cholesterol
test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits and
others. Glucose testing held 40% share of the overall market in terms of revenue in 2016.
Increasing prevalence of diabetes across the globe is expected to boost the demand for glucose
testing in the years to come. The infectious diseases testing kits is expected to grow at the
highest CAGR during the forecast period on account of the rise in a number of HIV-infected
individuals.
Some of the key prescription mode present in the market such as prescription based kits and
over the counter kits. Prescription-based testing kits are expected to dominate the market in the
near future due to increasing incidence of lifestyle diseases and lack of awareness on over the
counter POCT devices.

Point Of Care Diagnostics Market
Based on the end-user, the market can be segmented into hospitals, clinics, and ambulatory
care settings. Clinic segment was the leading segment and it accounted for the large chunk of
market share in 2016. Increasing adoption of these tests in the clinics for diagnosis of several
infections and monitoring of disease progression by assessment of symptoms and other
parameters is expected to boost the demand for POCT in this segment. Home health care is
another important segment of this segment.
The global point of care market was dominated by North America with over 42% share of the
total market in 2016. This growth is mainly due to increased prevalence of diseases in the
region and presence of favorable government regulations and initiatives pertaining to the
development of healthcare infrastructure. Asia Pacific is another important regional market and
is expected to show witness fastest growth in the near future. This can be attributed to the
presence of high unmet medical needs and technological advancement in healthcare
infrastructure, growing medical awareness, and rise in per capita income levels in developing
economies of including India and China.
Some of the key players in the market such as Roche Diagnostics, Alere Inc ., Danaher
Corporation, Abbott Laboratories, Johnson and Johnson, Instrumentation Laboratory, Trinity
Biotech PLC, OraSure Technologies Inc, bioMerieux, Qiagen N.V. and Siemens Healthcare.
Browse the full “Point Of Care Diagnostics Market by Products, by Prescription Mode
(Prescription-Based Testing Kits and Over-the-Counter Testing Kits) Market for
Hospitals, Clinics and Ambulatory Care Settings: Global Industry Perspective,
Comprehensive Analysis, and Forecast, 2016 – 2022” report
at https://www.zionmarketresearch.com/report/point-of-care-diagnostics-market

Point Of Care Diagnostics Market
Zion Market Research
Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT +49-322 210 92714
Tel: +1-855-465-4651 (US/CAN TOLL FREE)
Email: sales@zionmarketresearch.com Web: www.zionmarketresearch.com